- Home
- ONL vs PROC Comparison
ONL vs PROC Comparison
Compare ONL & PROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONL
- PROC
- Stock Information
- Founded
- ONL 2021
- PROC 1976
- Country
- ONL United States
- PROC Luxembourg
- Employees
- ONL N/A
- PROC N/A
- Industry
- ONL Real Estate Investment Trusts
- PROC Biotechnology: Pharmaceutical Preparations
- Sector
- ONL Real Estate
- PROC Health Care
- Exchange
- ONL Nasdaq
- PROC Nasdaq
- Market Cap
- ONL 226.6M
- PROC 203.1M
- IPO Year
- ONL N/A
- PROC N/A
- Fundamental
- Price
- ONL $4.01
- PROC $1.10
- Analyst Decision
- ONL Hold
- PROC
- Analyst Count
- ONL 1
- PROC 0
- Target Price
- ONL N/A
- PROC N/A
- AVG Volume (30 Days)
- ONL 252.5K
- PROC 68.7K
- Earning Date
- ONL 11-07-2024
- PROC 11-26-2024
- Dividend Yield
- ONL 9.97%
- PROC N/A
- EPS Growth
- ONL N/A
- PROC N/A
- EPS
- ONL N/A
- PROC 0.52
- Revenue
- ONL $169,644,000.00
- PROC $414,096,000.00
- Revenue This Year
- ONL N/A
- PROC $5.54
- Revenue Next Year
- ONL N/A
- PROC $8.54
- P/E Ratio
- ONL N/A
- PROC $1.11
- Revenue Growth
- ONL N/A
- PROC N/A
- 52 Week Low
- ONL $3.01
- PROC $0.50
- 52 Week High
- ONL $6.22
- PROC $4.95
- Technical
- Relative Strength Index (RSI)
- ONL 54.63
- PROC 41.91
- Support Level
- ONL $3.75
- PROC $0.50
- Resistance Level
- ONL $3.91
- PROC $1.76
- Average True Range (ATR)
- ONL 0.15
- PROC 0.18
- MACD
- ONL 0.01
- PROC -0.06
- Stochastic Oscillator
- ONL 71.76
- PROC 44.44
About ONL Orion Office REIT Inc.
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.
About PROC Procaps Group S.A.
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.